0001209191-20-041277.txt : 20200706 0001209191-20-041277.hdr.sgml : 20200706 20200706192943 ACCESSION NUMBER: 0001209191-20-041277 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200701 FILED AS OF DATE: 20200706 DATE AS OF CHANGE: 20200706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LOBERG MICHAEL D CENTRAL INDEX KEY: 0001233414 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39045 FILM NUMBER: 201014849 MAIL ADDRESS: STREET 1: C/O ARQULE, INC. STREET 2: 1 WALL STREET, 6TH FLOOR CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IGM Biosciences, Inc. CENTRAL INDEX KEY: 0001496323 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770349194 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 325 E MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-965-7873 MAIL ADDRESS: STREET 1: 325 E MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 FORMER COMPANY: FORMER CONFORMED NAME: Palingen, Inc. DATE OF NAME CHANGE: 20100712 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-01 0 0001496323 IGM Biosciences, Inc. IGMS 0001233414 LOBERG MICHAEL D C/O IGM BIOSCIENCES, INC. 325 E. MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 1 0 0 0 Common Stock 2020-04-09 5 G 0 E 39803 0.00 D 535 D Common Stock 2020-04-09 5 G 0 E 39803 0.00 A 39803 I See footnote Common Stock 2020-04-17 5 G 0 E 39803 0.00 D 0 I See footnote Common Stock 2020-04-17 5 G 0 E 39803 0.00 A 39803 I See footnote Common Stock 2020-06-04 5 G 0 E 535 0.00 D 0 D Common Stock 2020-06-04 5 G 0 E 535 0.00 A 535 I See footnote Common Stock 2020-07-01 4 A 0 535 0.00 A 535 D The shares are held by the Revocable Deed of Trust of Michael D. Loberg (Michael and Melinda Loberg, Trustees), of which Reporting Person and his spouse serve as trustees. The shares are held by the Michael D. Loberg Qualified Annuity Interest Trust VII (Michael and Melinda Loberg, Trustees), of which Reporting Person and his spouse serve as trustees. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy. /s/ Misbah Tahir, by power of attorney 2020-07-06